3
Hindawi Publishing Corporation Journal of Drug Delivery Volume 2011, Article ID 343082, 2 pages doi:10.1155/2011/343082 Editorial Nanotechnology in Advanced Drug Delivery Sanyog Jain, 1 Ijeoma F. Uchegbu, 2 Guru Betageri, 3 and Giorgia Pastorin 4 1 Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, Phase X, SAS Nagar (Mohali), Punjab 160062, India 2 Department of Pharmaceutics, School of Pharmacy, University of London, 29 39 Brunswick Square, London WC1N 1AX, UK 3 Graduate College of Biomedical Sciences, Western University of Health Sciences, 309 E. Second Street, Pomona, CA 91766, USA 4 Department of Pharmacy, National University of Singapore, 3 Science Drive 2, Block S15, 05-PI-03, Singapore 117543 Correspondence should be addressed to Sanyog Jain, [email protected] Received 24 August 2011; Accepted 24 August 2011 Copyright © 2011 Sanyog Jain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Buzzing of nanotechnology in each and every aspect of science and technology has been booming at a tremendous rate now a day. Started its journey from inorganic chemistry, this field has now even reached to aeronautical research, and a special attention has been drawn in the medical and allied braches for exploitation of the nanotech for attending the limitations of the current scenario. Carrying foreword the success of nanotechnology in field of physical, chemical, and medical sciences, it has now started revolutionizing the drug delivery sciences. The specific advantages include su- perior pharmacodynamics, pharmacokinetics, reduced tox- icity, and targeting capability. Vehicle in the delivery sci- ences being critical quality attribute needs special atten- tion for tailor made design to rationalize the formulation development; which can be successfully achieved via nan- otechnology. Additionally, unique size-dependent properties of nanosystems/nanodevices oers excellent opportunities for the development of novel “point-of-care” devices and therapeutic tools. Drugs incorporated in the nanocarriers, either physically entrapped or chemically tethered, have the potential to target physiological disorder zone sparing nor- mal cells from collateral consequences. Targeting several molecular mechanisms, for either treat- ment or prevention of dicult-to-treat diseases, for the design of the various nanotechnology-based drug delivery systems is one of prime focuses of the formulation scientist at the present juncture. Gene therapies and gene-based drug delivery using nanocarriers are booming especially in case of neoplastic extravasations. Various tumor suppressor genes are identified, isolated and successfully formulated for treat- ment of cancer. A remarkable number of such systems have already made their pave and are under clinical trials, being expected very soon at the end user level. Besides treating these diseases, nanotechnology also oers its contributions in development of preventive measures such as vaccines. Various nanotechnological adjuvants have been evaluated for their capabilities to deliver vaccine subunits without compromising the immunogenicity for successful design and development of vaccine delivery systems. Furthermore, regeneration ability of the visceral organs such as liver has also been evaluated using nanocarriers, and the postulations are on their way stating the enhanced cytoactivity of the transplanted cells when cultured in nanocarriers. The pharmacokinetic profile, especially transportation capabilities, of the drug substances have been greatly mod- ified by incorporation in nanodrug delivery system. These include enhanced accommodation for targeting moieties such as chaperones and alteration in release rates comprising of controlled release and site-specific delivery by use of molecular engineering techniques. Additionally, encapsu- lation of the drug substances in various polymeric and inorganic composites has also been evaluated for their ratio- nalizing the drug delivery systems. Such encapsulations are generally made for protecting the biologically active protein and peptide-based drug compounds from the detrimental eects of biological fluids. Newer nanoprodrug approaches have also been applied, which has posed enhanced therapeu- tic ecacy along with superior circulation time. Emerging methodologies for formulation of nanodrug delivery systems include newer versions of the top-down and bottom-up approaches. Additionally allied technologies such as atomization and pressurization have come in to play

Editorial NanotechnologyinAdvancedDrugDeliverydownloads.hindawi.com/archive/2011/343082.pdf · design of the various nanotechnology-based drug delivery systems is one of prime focuses

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Editorial NanotechnologyinAdvancedDrugDeliverydownloads.hindawi.com/archive/2011/343082.pdf · design of the various nanotechnology-based drug delivery systems is one of prime focuses

Hindawi Publishing CorporationJournal of Drug DeliveryVolume 2011, Article ID 343082, 2 pagesdoi:10.1155/2011/343082

Editorial

Nanotechnology in Advanced Drug Delivery

Sanyog Jain,1 Ijeoma F. Uchegbu,2 Guru Betageri,3 and Giorgia Pastorin4

1 Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education andResearch (NIPER), Sector 67, Phase X, SAS Nagar (Mohali), Punjab 160062, India

2 Department of Pharmaceutics, School of Pharmacy, University of London, 29 39 Brunswick Square, London WC1N 1AX, UK3 Graduate College of Biomedical Sciences, Western University of Health Sciences, 309 E. Second Street, Pomona, CA 91766, USA4 Department of Pharmacy, National University of Singapore, 3 Science Drive 2, Block S15, 05-PI-03, Singapore 117543

Correspondence should be addressed to Sanyog Jain, [email protected]

Received 24 August 2011; Accepted 24 August 2011

Copyright © 2011 Sanyog Jain et al. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Buzzing of nanotechnology in each and every aspect ofscience and technology has been booming at a tremendousrate now a day. Started its journey from inorganic chemistry,this field has now even reached to aeronautical research,and a special attention has been drawn in the medical andallied braches for exploitation of the nanotech for attendingthe limitations of the current scenario. Carrying forewordthe success of nanotechnology in field of physical, chemical,and medical sciences, it has now started revolutionizing thedrug delivery sciences. The specific advantages include su-perior pharmacodynamics, pharmacokinetics, reduced tox-icity, and targeting capability. Vehicle in the delivery sci-ences being critical quality attribute needs special atten-tion for tailor made design to rationalize the formulationdevelopment; which can be successfully achieved via nan-otechnology. Additionally, unique size-dependent propertiesof nanosystems/nanodevices offers excellent opportunitiesfor the development of novel “point-of-care” devices andtherapeutic tools. Drugs incorporated in the nanocarriers,either physically entrapped or chemically tethered, have thepotential to target physiological disorder zone sparing nor-mal cells from collateral consequences.

Targeting several molecular mechanisms, for either treat-ment or prevention of difficult-to-treat diseases, for thedesign of the various nanotechnology-based drug deliverysystems is one of prime focuses of the formulation scientistat the present juncture. Gene therapies and gene-based drugdelivery using nanocarriers are booming especially in caseof neoplastic extravasations. Various tumor suppressor genesare identified, isolated and successfully formulated for treat-ment of cancer. A remarkable number of such systems have

already made their pave and are under clinical trials, beingexpected very soon at the end user level. Besides treatingthese diseases, nanotechnology also offers its contributionsin development of preventive measures such as vaccines.Various nanotechnological adjuvants have been evaluatedfor their capabilities to deliver vaccine subunits withoutcompromising the immunogenicity for successful designand development of vaccine delivery systems. Furthermore,regeneration ability of the visceral organs such as liver hasalso been evaluated using nanocarriers, and the postulationsare on their way stating the enhanced cytoactivity of thetransplanted cells when cultured in nanocarriers.

The pharmacokinetic profile, especially transportationcapabilities, of the drug substances have been greatly mod-ified by incorporation in nanodrug delivery system. Theseinclude enhanced accommodation for targeting moietiessuch as chaperones and alteration in release rates comprisingof controlled release and site-specific delivery by use ofmolecular engineering techniques. Additionally, encapsu-lation of the drug substances in various polymeric andinorganic composites has also been evaluated for their ratio-nalizing the drug delivery systems. Such encapsulations aregenerally made for protecting the biologically active proteinand peptide-based drug compounds from the detrimentaleffects of biological fluids. Newer nanoprodrug approacheshave also been applied, which has posed enhanced therapeu-tic efficacy along with superior circulation time.

Emerging methodologies for formulation of nanodrugdelivery systems include newer versions of the top-downand bottom-up approaches. Additionally allied technologiessuch as atomization and pressurization have come in to play

Page 2: Editorial NanotechnologyinAdvancedDrugDeliverydownloads.hindawi.com/archive/2011/343082.pdf · design of the various nanotechnology-based drug delivery systems is one of prime focuses

2 Journal of Drug Delivery

to facilitate the preparation of nanotechnological carriers.One such comprises a novel method of atomization, namely,electrohydrodynamic atomization used in electrosprayingmethod. Pressurization techniques such as high hydrostaticpressure technology for encapsulation of genes into polymer-ic nanomaterials have recently been studied for their efficacyin delivering the biologically active compounds. These noveltechnologies offer advantages by eliminating the usage oftoxic cationic polymers and chemical tethers further replac-ing them simple yet effective hydrogen bonding. Such ad-vantages and simplifications of the process have already giventheir imminent revolutions in the field of drug delivery.

With these advancements in the novel nanocarriers andtheir applicability, the analytical tools are also not laggingbehind. In order to cope up with this and stand aside, newerevaluation methodologies are already in move of their devel-opment. These include scanning probe microscopy, morespecifically atomic force microscopy and scanning tunnelingmicroscopy, which have great capabilities for molecular andsubmolecular characterizations.

Furthermore, various platform technologies at the nano-scale, often referred as nanoplatforms, have been comingin to play and booming for widespread applications ofthese cutting edge technologies for its applicability at endusers. Basically, the common ones in the race include thenanocrystals (nanopure, nanoedge, Dissocubes), nanoma-terials (fullerenes, carbon nanotubes, and nanoparticles),nanomedicines, molecular self-assemblies (self-assembledmonolayers, supramolecular assemblies and DNA nanotech-nologies), nanoelectronics (in silico technologies), and so onto name a few. The extension and appliance will be the state-of-art for future research.

Finally, the common undeniable opinion highlighted inthis issue is that, although it is too early to say whetherthese nanocarriers will wean the world from its currentlimitations, or monumentally backfire to cause harm, a deepunderstanding of the various mechanisms underneath thereported findings will favor great discoveries, even at thenanoscale.

In nutshell, efforts are extensively made for utilizing thenanotechnology concepts for advancements in the currentdrug delivery sciences and, further to this, the fruitfulness ofthe efforts has been achieved which is well reflected in thispresent issue.

Sanyog JainIjeoma F. Uchegbu

Guru BetageriGiorgia Pastorin

Page 3: Editorial NanotechnologyinAdvancedDrugDeliverydownloads.hindawi.com/archive/2011/343082.pdf · design of the various nanotechnology-based drug delivery systems is one of prime focuses

Submit your manuscripts athttp://www.hindawi.com

PainResearch and TreatmentHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com

Volume 2014

ToxinsJournal of

VaccinesJournal of

Hindawi Publishing Corporation http://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

AntibioticsInternational Journal of

ToxicologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

StrokeResearch and TreatmentHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Drug DeliveryJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Advances in Pharmacological Sciences

Tropical MedicineJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Medicinal ChemistryInternational Journal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

AddictionJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

BioMed Research International

Emergency Medicine InternationalHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Autoimmune Diseases

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Anesthesiology Research and Practice

ScientificaHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Pharmaceutics

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

MEDIATORSINFLAMMATION

of